Literature DB >> 7283404

Humoral immunity in Guamanians with amyotrophic lateral sclerosis and parkinsonism-dementia.

P M Hoffman, D S Robbins, M B Oldstone, C J Gibbs, D C Gajdusek.   

Abstract

Among Guamanian natives, serum IgA and IgG levels were found to be higher than normal in amyotrophic lateral sclerosis (ALS); serum IgA was higher and IgM lower than normal in parkinsonism-dementia (PD). IgA levels increased with age in ALS, PD, and normal subjects; IgG increased with age in ALS and IgM decreased with age in PD. Serum immunoglobulin (Ig) levels did not correlate with the duration of either disease. Immunodeficient ALS and PD patients had higher IgM and lower IgA levels than the other ALS and PD patients. Neither differences in viral antibody titers nor the presence of autoantibodies or circulating immune complexes could account for the variations in serum Ig levels between patients and controls. We conclude that differences in serum Ig levels in ALS and PD patients are probably due to repeated infections and abnormal immunoregulation accompanying immunodeficiency during the course of ALS and PD, rather than to a specific antiviral or autoimmune response.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7283404     DOI: 10.1002/ana.410100210

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  7 in total

1.  Association of amyotrophic lateral sclerosis, Hoigne's syndrome and residence in Guam.

Authors:  P O Behan; A M Bakheit
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

Review 2.  Immunology of amyotrophic lateral sclerosis.

Authors:  N R Cashman; M E Gurney; J P Antel
Journal:  Springer Semin Immunopathol       Date:  1985

Review 3.  CD4 + T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease.

Authors:  Kathryn J Jones; Amy E Lovett-Racke; Chandler L Walker; Virginia M Sanders
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-07       Impact factor: 4.147

Review 4.  Neuroinflammation in Parkinson's Disease - Putative Pathomechanisms and Targets for Disease-Modification.

Authors:  Alexander Grotemeyer; Rhonda Leah McFleder; Jingjing Wu; Jörg Wischhusen; Chi Wang Ip
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

Review 5.  TRPM7 and TRPM2-Candidate susceptibility genes for Western Pacific ALS and PD?

Authors:  Meredith C Hermosura; Ralph M Garruto
Journal:  Biochim Biophys Acta       Date:  2007-02-24

6.  Peripheral Humoral Immune Response Is Associated With the Non-motor Symptoms of Parkinson's Disease.

Authors:  Congcong Sun; Wenfei Yu; Zhenxiang Zhao; Chengyuan Song; Ying Liu; Guoyong Jia; Xingbang Wang; Yiming Liu
Journal:  Front Neurosci       Date:  2019-10-10       Impact factor: 4.677

7.  Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.

Authors:  Rebecca Banerjee; R Lee Mosley; Ashley D Reynolds; Alok Dhar; Vernice Jackson-Lewis; Paul H Gordon; Serge Przedborski; Howard E Gendelman
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.